HFS
CAPR icon

Hughes Financial Services’s Capricor Therapeutics CAPR Stock Holding History

Hughes Financial Services’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289 Buy
12
+1
+9% +$30 ﹤0.01% 1199
2026
Q1 		$334 Buy
+11
New +$293 ﹤0.01% 997

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hughes Financial Services's CAPR Position: Q2 2026 in Review

Hughes Financial Services increased its Capricor Therapeutics (CAPR) stake by 9.1% in Q2 2026, buying an estimated $30 and bringing the position to 12 shares worth $289. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Hughes Financial Services first reported a position in CAPR in Q1 2026 and has held it in 2 quarters since. The position peaked at $334 in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Hughes Financial Services held 12 shares of Capricor Therapeutics worth $289 as of Q2 2026.
  • Hughes Financial Services bought 1 Capricor Therapeutics share in Q2 2026, an estimated $30.
  • Capricor Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1199 holding.
  • Hughes Financial Services first reported a position in Capricor Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Hughes Financial Services's Capricor Therapeutics position peaked at $334 in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.